Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light

NCT03176485 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03176485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light
Lead sponsor
University of Arizona
Phase
Not applicable
Overall status
Completed
Start date
October 17, 2014
Completion date
November 1, 2018
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, differentiated thyroid cancer, hcc, hepatocellular carcinoma, melanoma, metastatic cancer, metastatic colon cancer, metastatic melanoma, renal cell carcinoma